People Frances Benson 9/20/23 People Frances Benson 9/20/23

Rezo Therapeutics appoints Nadir Mahmood as CEO

Read More

Financing and Partnerships Frances Benson 9/6/23 Financing and Partnerships Frances Benson 9/6/23

Nimbus Therapeutics secures $210M in private financing

Read More

Financing and Partnerships Frances Benson 8/23/23 Financing and Partnerships Frances Benson 8/23/23

FORE Biotherapeutics announces $75M in Series D and CEO Transition

Read More

Financing and Partnerships Frances Benson 8/9/23 Financing and Partnerships Frances Benson 8/9/23

ADARx Pharmaceuticals announces oversubscribed $200M Series C

Read More

Clinical Impact Frances Benson 7/6/23 Clinical Impact Frances Benson 7/6/23

Simcha Therapeutics announces first patient dosed in Ph1/2 study evaluating ST-067 in combination with KEYTRUDA® (Pembrolizumab)

Read More

People Frances Benson 7/5/23 People Frances Benson 7/5/23

Nkarta appoints Alyssa Levin CBO and CFO

Read More

Clinical Impact Frances Benson 6/8/23 Clinical Impact Frances Benson 6/8/23

FDA accepts biologics license applications for exagamglogene autotemcel (exa-cel) for severe sickle cell disease and transfusion-dependent beta thalassemia

Read More

Clinical Impact Frances Benson 4/11/23 Clinical Impact Frances Benson 4/11/23

HotSpot Therapeutics achieves first-in-human dosing with HST-1011, an investigational oral small molecule Allosteric Inhibitor of CBL-B

Read More

Financing and Partnerships Frances Benson 4/5/23 Financing and Partnerships Frances Benson 4/5/23

Simcha Therapeutics announces clinical trial collaboration with Merck to evaluate ST-067 in combination with KEYTRUDA® (Pembrolizumab)

Read More

Notable Frances Benson 3/27/23 Notable Frances Benson 3/27/23

SR One Closes Second Venture Fund at $600M

Read More

Notable Frances Benson 2/14/23 Notable Frances Benson 2/14/23

Mineralys Therapeutics prices $221M IPO

Read More

Financing and Partnerships Frances Benson 1/20/23 Financing and Partnerships Frances Benson 1/20/23

ADARx Pharmaceuticals raises $46M in Series B-1 and appoints Dr. Lorence Kim to Board of Directors

Read More

People Frances Benson 1/9/23 People Frances Benson 1/9/23

ADARx Pharmaceuticals appoints Robert MacLeod as CSO

Read More

Financing and Partnerships Frances Benson 1/5/23 Financing and Partnerships Frances Benson 1/5/23

Akamis Bio raises $30M financing and relaunches with name change from PsiOxus Therapeutics

Read More

Clinical Impact Frances Benson 1/3/23 Clinical Impact Frances Benson 1/3/23

HotSpot Therapeutics announces FDA clearance of IND application for HST-1011, an investigational small molecule allosteric inhibitor of CBL-B

Read More

Notable Frances Benson 12/13/22 Notable Frances Benson 12/13/22

Nimbus Therapeutics TYK2 program to be acquired by Takeda for $4B in upfront cash and up to $2B in potential commercial milestone payments

Read More

Notable Frances Benson 12/9/22 Notable Frances Benson 12/9/22

Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma

Read More

Financing and Partnerships Frances Benson 12/6/22 Financing and Partnerships Frances Benson 12/6/22

HotSpot Therapeutics launches strategic collaboration with AbbVie to further expand immunology pipeline

Read More

Clinical Impact Frances Benson 11/30/22 Clinical Impact Frances Benson 11/30/22

Nimbus Therapeutics announces positive topline results for Ph2b clinical trial of allosteric TYK2 inhibitor

Read More

New investments Frances Benson 11/17/22 New investments Frances Benson 11/17/22

Rezo Therapeutics, founded by renowned UCSF scientists, raises $78M in Series A

Read More